⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1865039 | 0.87 | — | — | |
| SCHEMBL1145883 | 0.76 | — | — | |
| SCHEMBL13224669 | 0.76 | — | — | |
| SCHEMBL2769789 | 0.73 | — | — | |
| SCHEMBL2642180 | 0.72 | — | — | |
| SCHEMBL2642183 | 0.72 | — | — | |
| SCHEMBL1869858 | 0.70 | — | — | |
| SCHEMBL32687124 | 0.69 | — | — | |
| SCHEMBL283508 | 0.67 | — | — | |
| SCHEMBL2967529 | 0.67 | NOS3 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107328-A1 | AGONISTS OF PARATHYROID HORMONE 1 AND INCRETIN RECEPTORS | SEPTERNA, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260055087-A1 | INHIBITORS OF LRRK2 KINASE | HALIA THERAPEUTICS INC (US) | 2026-02-26 | — | — | US | disclosed |
| US-20260042759-A1 | INHIBITOR CONTAINING BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) | 2026-02-12 | — | — | US | disclosed |
| EP-4288426-B1 | QUINOXALINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS INC (US) | 2026-02-04 | — | — | EP | disclosed |
| US-12528815-B2 | 5-amino-8-(4-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-3-one compounds for use against cancer | NXERA PHARMA UK LIMITED (GB) | 2026-01-20 | — | — | US | disclosed |
| US-12466823-B2 | Inhibitor containing bicyclic derivative, preparation method therefor and use thereof | SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) | 2025-11-11 | — | — | US | disclosed |
| US-12428404-B2 | Inhibitors of LRRK2 kinase | Halia Therapeutics, Inc. (US) | 2025-09-30 | — | — | US | disclosed |
| EP-3971187-B1 | INHIBITOR CONTAINING BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) | 2025-05-07 | — | — | EP | disclosed |
| US-20240368181-A1 | QUINOXALINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2024-11-07 | — | — | US | disclosed |
| US-20240317706-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2024-09-26 | — | — | US | disclosed |
| WO-2016177655-A1 | TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES AS INHIBITORS OF HBSAG (HBV SURFACE ANTIGEN) AND HBV DNA PRODUCTION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTIONS | F. HOFFMANN-LA ROCHE AG (CH) | 2016-11-10 | — | — | WO | disclosed |
| US-20160326167-A1 | Novel Tetrahydropyridopyrimidines and Tetrahydropyridopyridines for the Treatment and Prophylaxis of Hepatitis B Virus Infection | HOFFMANN-LA ROCHE INC. (US) | 2016-11-10 | — | — | US | disclosed |
| US-9006456-B2 | Processes for the preparation of thietanamine | SYNGENTA PARTICIPATIONS AG (CH) | 2015-04-14 | — | — | US | disclosed |
| US-20140187788-A1 | PROCESSES FOR THE PREPARATION OF THIETANAMINE | SYNGENTA PARTICIPATIONS AG (CH) | 2014-07-03 | — | — | US | disclosed |
| EP-1482002-B1 | POLYMERIZABLE COMPOSITION CONTAINING NOVEL CYCLIC SULFUR COMPOUND AND RESIN OBTAINED BY CURING THE POLYMERIZABLE COMPOSITION | MITSUI CHEMICALS INC (JP) | 2010-04-28 | — | — | EP | disclosed |
| CN-1286883-C | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS INC (JP) | 2006-11-29 | — | — | CN | disclosed |
| US-7132501-B2 | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS, INC. (JP) | 2006-11-07 | — | — | US | disclosed |
| US-20050215757-A1 | Polymerizable composition containing novel cyclic sulfur compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS, INC. (JP) | 2005-09-29 | — | — | US | disclosed |
| CN-1596276-A | Polymerizable composition comprising novel sulfur-containing cyclic compound and resin obtained by curing the polymerizable composition | MITSUI CHEMICALS INC (JP) | 2005-03-16 | — | — | CN | disclosed |
| EP-1482002-A1 | POLYMERIZABLE COMPOSITION CONTAINING NOVEL CYCLIC SULFUR COMPOUND AND RESIN OBTAINED BY CURING THE POLYMERIZABLE COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2004-12-01 | — | — | EP | disclosed |